Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Clinicians are also looking at how CagriSema might help with related conditions such as fatty liver disease, insulin resistance, and cardiometabolic risk
Endocrinology , 161
The retatrutide triple agonist GLP-1 GIP glucagon mechanism works through three parallel axes: GLP-1 receptor activation: Stimulates glucose-dependent insulin secretion from pancreatic beta cells, suppresses glucagon release from alpha cells, slows gastric emptying, and reduces appetite signalling in the hypothalamus
Mechanism of Action: Semaglutide GLP-1 works by activating GLP-1 receptors in the brain and pancreas, resulting in several key benefits: Delayed Gastric Emptying: By slowing the rate at which food exits the stomach, semaglutide GLP-1 helps promote a feeling of fullness and reduces hunger, assisting in decreased calorie consumption
.png?w=1280&max-h=720&fit=crop&auto=format)
